ASCI / Young Physician-Scientist Awards, 2022
The Young Physician-Scientist Awards (YPSA) recognize physician-scientists who are early in their first faculty appointment and have made notable achievements in their research.
About the awardee
Adam David Durbin, MD, PhD, received his BSc from York University, followed by his Medical degree and PhD at the University of Toronto. He performed residency training in the Boston Combined Residency Program in Pediatrics and fellowship training in the Dana-Farber Cancer Institute/Boston Children’s Hospital Pediatric Hematology/Oncology fellowship. He performed post-doctoral research with Tom Look and Kim Stegmaier at DFCI and the Broad Institute studying the dependency landscape of high-risk pediatric solid tumors, including neuroblastoma and rhabdomyosarcoma. During this time, Dr. Durbin identified cohorts of reprogramming transcription factors responsible for establishing the malignant transcriptome in these high risk cancers. In 2020, Dr. Durbin was appointed to the faculty of St. Jude Children’s Research Hospital as an Assistant Member in the Division of Molecular Oncology, Department of Oncology and the Developmental Biology and Solid Tumor Program. Dr. Durbin’s laboratory seeks to understand how transcriptional regulatory circuitries establish malignant cell identity, and how these circuitries can be perturbed for clinical benefit using conventional and novel small molecules. Dr. Durbin has received numerous awards and grants from the National Institutes of Health, Damon Runyon Cancer Research Foundation, Rally Foundation for Childhood Cancer Research, Alex’s Lemonade Stand Foundation, Forbeck Foundation, CureSearch for Children’s Cancer and the American Society of Clinical Oncology.